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Abstract
Background/Aim. World Health Organization (WHO)
studies on the global level have shown that one of the major
problems of the public health is hypertension. Blood pres-
sure level greater than 140/90 mmHg is directly and predic-
tively linked to other cardiovascular diseases. The aim of
this research was to determine the prevalence of hyperten-
sion and the risk groups among the adult population in the
Šumadija District, Serbia. Methods.  This cross-sectional
study included 1.669 elderly population of the Šumadija
District, aged 25–74. The study was performed according to
the protocol of the Countrywide Integrated Noncommuni-
cable Disease Intervention (CINDI) international program.
Results. In the Šumadija District more than a half of the
population aged 25–74 suffers from hypertension (53%). In
the Šumadija District 9% of population has undiagnosed
hypertension. In the group of people familiar with their
high blood pressure problems, good disease control is
achieved in only 46% of them. Statistically, hypertension
occurs more frequently in males aged 45–74, of lower edu-
cation, and in rural population. This is the target group for
implementation of the high risk strategy. Statistically, there
is a higher prevalence of hypertension in people suffering
from myocardial infarction (p = 0.04),  angina  pectoris
(p = 0.00), other cardiac diseases (cardiac insufficiency) (p =
0.00) and cerebrovascular crises (p = 0.04). Conclusion. A
continuous increase of patients with hypertension, coupled
with the developed complications and increase in cardiovas-
cular diseases as a cause of death, points to the lack of ef-
fective access to prevention and early detection of these dis-
eases in the primary health care among the risk groups in
Šumadija.
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Apstrakt
Uvod/Cilj. Istraživanja Svetske zdravstvene organizacije na
globalnom nivou pokazala su da je hipertenzija jedan od
najveýih problema narodnog zdravlja. Visina krvnog pritiska
iznad 140/90 mmHg  direktno ukazuje na povezanost sa
drugim kardiovaskularnim bolestima (KVD). Bolesti srca i
krvnih sudova u Srbiji u 2006. godini su u strukturi mortali-
teta ÿinile više od polovine svih smrtnih ishoda. Cilj ovog
istraživanja bio je da se utvrdi prevalencija hipertenzije, kao i
riziÿne grupe kod odraslih stanovnika Šumadije. Metode.
Ova studija preseka obuhvatala je reprezentativni uzorak od
1  669 odraslih u Šumadiji, starosti 25–74 godine, koji je
formiran u skladu sa protokolom meĀunarodnog programa
Countrywide Integrated Noncommunicable Diseases Intervention
(CINDI). Rezultati. U Šumadiji više od polovine stanovni-
štva (53%), starosti 25–74 godine ima hipertenziju. Novoot-
krivenu hipertenziju ima 9% stanovnika Šumadijskog okru-
ga. U grupi osoba koje su znale da imaju povišen krvni priti-
sak dobra kontrola bolesti postignuta je samo kod 46%. Hi-
pertenzija se statistiÿki ÿešýe javljala kod ispitanika muškog
pola, starosti 45–74 godine, kod ispitanika nižeg obrazova-
nja i seoskog stanovništva. Ovo su ciljne grupe za primenu
strategije visokog rizika.  Postoji statistiÿki znaÿajno veýa
uÿestalost hipertenzije kod osoba koje boluju od infarkta
miokarda (p = 0,04), angine pektoris (p = 0,00), drugih bole-
sti srca (srÿana insuficijencija) (p = 0,00) i cerebrovaskular-
nih kriza (p = 0,04). Zakljuÿak. Neprekidan porast obole-
vanja od hipertenzije, skopÿano s razvojem komplikacija i
porastom udela kardiovaskularnih bolesti u strukturi uzroka
smrti, ukazuje na nedovoljno efikasan pristup prevenciji i
njihovom ranom otkrivanju na nivou primarne zdravstvene
zaštite kod riziÿne grupe u Šumadiji.
Kljuÿne reÿi:
hipertenzija; srbija; prevalenca; incidenca; faktori
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Introduction
The epidemic of cardiovascular diseases (CVDs) in the
world marked the 20th century with a clear tendency to keep
the trend of increasing prevalence in many countries as well
as in the 21st century. The increasing prevalence of CVD,
primarily linked to aging population, and the population in
Serbia is among the oldest in Europe 
1, 2.
In the world, according to the World Health Organization
(WHO), in 2006 from heart and vascular diseases died 17.5
million people, accounting for 30% of all deaths. In European
countries, in the same year there were 5.1 million deaths, rep-
resenting 52% of all deaths 
3. Deaths from heart and blood
vessels diseases in Serbia in 2006 were more than half of all
deaths (57.3%). The standardized heart and vascular mortality
rate diseases in Serbia in 2006 was 567.0 deaths per 100,000
population (in Central Serbia, 544.2). Compared to the average
mortality rate in Europe of 479.4 per 100,000 population, Ser-
bia was in that year in a group of countries with a high risk of
daying from cardiovascular diseases 
4, 5.
Hypertension is a major risk of damaging blood vessels
and consequent organ damage, especially heart, kidney and
brain 
6. Studies on risks of mortality and morbidity, con-
ducted by the WHO at the global level, have shown that hy-
pertension is one of the biggest public health problems. It is
shown that this disease is a higher risk factor of all the identi-
fied factors, such as consumption of tobacco smoke, hyper-
cholesterolemia and obesity, even in developing coun-
tries 
7, 9. Hypertension is attributed to 9.7% of total years of
life lost (YLL) due to premature death for males and 13.3%
for women 
10.
Hypertension is defined as the value of blood pressure
which causes a higher risk of adverse consequences in the
form of organ damage. That results in the increased cost of
treatment of hypertension 
6. According to the definition of
hypertension, based on criteria adopted by consensus JNC 7
(Joint Committee on Detection, Evaluation and Treatmant of
High Blood Pressure) 
11, hypertension is a permanent in-
crease in arterial blood pressure to the values above 140
mmHg  in systole and 90 mmHg in diastole. Elevation of
blood pressure above 140/90 mmHg 
11, 12 is a continuous,
gradual, consistent, independent and directly predictive, as-
sociated with apoplexy, coronary artery disease, chronic re-
nal disease progression 
13, 14, thus with that value of blood
pressure it is necessary to start treatment urgently for all ap-
plicable protocols 
11.
The aim of this study was to determine the prevalence
of hypertension in the population of adults in the Šumadija
District, Serbia, and risk groups for the diseases such as hy-
pertension and its association with other cardiovascular dis-
eases.
Methods
This research was a part of the project "Capacity
building of primary health care for the primary prevention of
chronic disease-development model" implemented at the In-
stitute of Public Health, Kragujevac, in 2011. Epidemiologi-
cal studies in a type-sectional study was conducted on a rep-
resentative sample of the Šumadija District population, aged
25–74 years. The study was conducted in 7 municipalities of
Šumadija: Kragujevac, Aranÿelovac, Topola, Raþa, Lapovo,
Batoþina and Kniü. The study of each municipality included
the number of patients proportional to the number of inhabi-
tants per municipality in Šumadija, aged 25–74 years. The
sample consisted of 1,850 respondents, but 181 subjects were
excluded from the study. Exclusion criteria were: incomplete
survey data relevant to this research and irregular blood pres-
sure. The sample was divided, by the age of respondents,
into 5 groups: 25–34, 35–44, 45–54, 55–64, 65–74. Within
these defined groups, the same number of males and females
was randomly included according to the list received from
the Serbian Ministry of Internal Affairs. The final sample
consisted of 1,669 respondents, 50.8% males and 49.2% fe-
males.
The investigation protocol was developed in accordance
with the protocol of the international Countrywide Integrated
Noncommunicable Diseases Intervention (CINDI) program
15. The data surveyed were collected, systemic examination
of subjects, other anthropometric measurements and labora-
tory analyzes were performed.
The survey respondents were conducted by the physi-
cians (respondents in the households or in the office of the
Health Center), "face to face." A systematic review of the
subjects was done by the physician at the Health Center.
Blood pressure was measured during systematic examination
3 times at 1-minute intervals. Blood pressure elevation was
obtained as the mean value of systolic and diastolic blood
pressures of the second and third measurements.
We defined 4 categories of hypertension as follows:
no hypertension, newly identified, controlled and uncon-
trolled hypertension, based on the values of blood pressure
measured at examination by a physician, and on the an-
swers given by the examinees to 2 questions: 1) Did a
doctor or other health worker tell you that you have high
blood pressure during last year (12 months)?, and 2) Do
you regularly take drugs that your doctor has prescribed
you to lower blood pressure?
Based on measurement data and the answers to these
questions they were classified into 4 subgroups: no hyperten-
sion (doctor found no hypertension, it was under control
amounting to <  140/90 mmHg; newly identified hyperten-
sion ( 140/90 mmHg); controlled hypertension (<  140/90
mmHg); uncontrolled hypertension ( 140/90 mmHg).
According to the analysis of associated diseases and
conditions the subjects were classified into 2 categories: no
hypertension; yes hypertension (uncontrolled hypertension).
The study was conducted in accordance with the ethical
standards of the Declaration of Helsinki 1975, revised in
1983. The study was approved by the Ethics Committee of
the Institute of Public Health in Kragujevac, and each re-
spondent was familiar with the aims and methods of the
study, and in connection with the information sheet and
signed consent to participate in the survey.
For statistical analysis we used SPSS Kall and software
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variables the Ȥ
2 test used. Hypertension was considered de-
pendent, all other variables were independent.
Results
At the time of the study we measured high blood pres-
sure in 32.4% of the representative sample. Another 20.1%
of them knew to have hypertension but and regularly took
medication, which and their blood pressure was normal at the
time of blood pressure testing.
The results of measurements at the time of study were
classified on the basis of the ESH/ ESC 2007 (ESH – Euro-
pean Society of Hypertension, ESC – European Society of
Cardiology) 
12. The majority of people with hypertension had
mild hypertension, 22.3% (grade I). High-normal pressure
(130/85 to 139/89 mmHg) had 17.7% of the population.
Moderate hypertension (grade II) was established in 7.9%,
and severe (grade III) in 2.2% of respondents. Blood pres-
sure > 160/100 mmHg had as many as 10% of the Šumadija
population (Figure 1).
In Šumadija more than half of the population aged 25–
74 had hypertension. One out of 5 people with hypertension
did not previously know to have this disease. This study also
found that 9% of the Šumadija population had a newly dis-
covered hypertension (incidence). In addition, good disease
control was achieved in 46% of people be awaring to have
high blood pressure, and the disease was not well controlled
in more than half of cases previously diagnosed with hyper-
tension (Figure 2).
The categories of hypertension in relation to socioeco-
nomic characteristics are shown in Table 1.
Fig. 1 – Frequency of blood pressure values in the classified
groups (ESH/ESC 2007) in the Šumadija District, Serbia,
during the research.
Fig. 2 – Prevalence of hypertension subgrups among the
population of the Šumadija District, Serbia.
Table 1
Categories of hypertension in relation to some sociodemographic characteristics
Hypertension (% of patients) Characteristics of populations
(n = 1669) no controlled uncontrolled newly discovered
Patients 47.3 20.1 23.6 9.0
Sex
male 44.2 19.1 25.2 11.5*
female 50.4 21.0 22.1 6.5*
Age groups, (years)
25–34 80.8** 6.9** 7.0** 5.3*
35–44 67.4** 10.5** 11.1** 11.0
45–54 45.1 23.6 20.9 10.4
55–64 24.1** 31.9** 34.7** 9.3
65–74 15.0** 27.1* 49.3** 8.6
Education
primary 27.4** 22.1 41.1** 9.2
secondary 50.6 21.1 19.1** 9.3
high 60.3** 15.2* 16.6** 7.9
The percentage of income for food 43.1 22.0 28.1 6.8
< 30 49.6 19.0 21.6 9.8
31–50 44.5 21.2 25.1 9.2
51–70 49.6 20.1 23.6 6.7
> 71
Type of settlement
city 52.2 21.7 18.8** 7.3
suburb 45.4 20.9 26.1 7.6
village 42.1 17.5 28.4* 12.0*
Values given as percentages of the hypertension variables by the category within the examined sociodemographic characteris-
tics, and expressed as percentages of sequence (the sum of the percent in the line is 100%); n = total number of patients;
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The males were more likely to suffer from hypertension
than the females (55% vs 50%), and there were no significant
intergroup differences among categories with respect to sex
(p = 0.000). A significant deviation from the average was in
the population of newly discovered hypertension (9.0%) by
sex, p <0.05, while women had a lower frequency (6.6%),
and men had a higher incidence of newly detected hyperten-
sion (11.5%). The males were more likely to have uncon-
trolled hypertension (25.2%) than the females (22.1%), but
with no statistical significance compared to the average fre-
quency.
Hypertension is a disease of the elderly and its inci-
dence increases in proportion to age. In the age groups 55–64
and 65–74 the incidence of hypertension was 76–85%. It was
significant that in the age group 45–54 the percentage of
people with hypertension exceeded 50%. Also, one out of 5
people aged 25–34, and one out of 3 people aged 35 to 44
years had hypertension. Analysis of categories of hyperten-
sion by age groups showed the expected results, namely sta-
tistically significantly higher incidence of controlled and un-
controlled hypertension in people older than 55 years. The
incidence of uncontrolled hypertension was highest among
the oldest respondents, 65–74 (49.3%). Surprisingly, a high
prevalence of newly detected hypertension was in the age
group 35–44 (11.0%), and 45–54 (10.4%), showing that
every 10th person in these age groups did not know to have
hypertension.
No significant incidence of hypertension was found in
relation to the socioeconomic status of the respondents (p =
0.40).
Hypertension was more common in people living in ru-
ral areas compared to the suburbs and the cities (58% vs 55%
of village vs suburban city 48% p = 0.00). The incidence of
uncontrolled (28.4%) and newly discovered (12.0%) hyper-
tension among residents of villages in Šumadija was signifi-
cantly higher than the average frequency of these categories
of hypertension in the city population (p < 0.05), while city
dwellers had less frequent uncontrolled hypertension, 18.8%
(p = 0.01).
The incidence of the other cardiovascular diseases,
which are also complications of hypertension, is shown in
Table 2.
There were a statistically significant intergroup differ-
ences in the incidence of myocardial infarction, angina pec-
toris, other heart diseases (heart failure) and cerebrovascular
crises in people with hypertension.
Of all the people with heart attack, 71% had hyperten-
sion, and 73% had other heart diseases (heart failure). People
with angina pectoris had hypertension in 85%, cases, which
was significantly more likely than the average (p <  0.01).
There were no significant differences in the incidence of dis-
eases such as stroke (p = 0.97).
Discussion
Analysis of data on the prevalence of hypertension at
the global level indicates that the increase in prevalence was
expected. In 2000 the prevalence of hypertension was 26.4%;
in 2010 we had the planned increase by 50% 
16, and by the
2025 will be it more than 60% 
7.
The first health survey conducted on a representative
sample in 2000 in Central Serbia, showed hypertension in
43.3% aged 19 and over, in 2006 it was 46.0% 
5. Our results
showing the incidence of hypertension of 53% in Šumadija
indicate further increase in the prevalence of hypertension in
this area, with an increase of 10% in 10 years, the greater in-
crease trend than in developed countries. In the United States
an increasing prevalence of 8.3% was found between studies
in 1988–94 and 1999–2000 
17. The Canadian study showed
that hypertension was increased from 153.1 per 1,000 adults
in 1995, to 244.8 per 1,000 adults in 2005, an increase in the
relative risk of > 60% 
18. Increasing age of Serbian popula-
Table 2
Cardiovascular disease (CVD) association with hypertension
Hypertension (% of patients) Type of CDV (n = 1669) without with
All comorbidities 47.3 52.7
Myocardial infarction
without 47 53
with 29 71
Angina pectoris
without 48 52
with 15* 85*
Other heart related issues
without 49 51
with 27* 73*
Stroke
without 47 53
with 38 62
Cerebrovascular crisis
without 47 53
with 25 75
Values in the table are given as percentages of the hypertension variables by catego-
ries of variables in the CVD, and expressed as percentages of sequence (the sum of
the percent in the line is 100%); n = total number of patients; *p < 0.01.Volumen 71, Broj 3 VOJNOSANITETSKI PREGLED Strana 249
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tion 
2 is definitely one of the important factors, but can not be
crucial for such a dramatic increase in the prevalence of hy-
pertension. Education as an independent factor was associ-
ated with hypertension in several studies 
19, 20. In our study it
was shown that subpopulations of lower educated persons
represent a risk group for increased morbidity from hyper-
tension, with particularly high prevalence of uncontrolled
hypertension and newly discovered. People with lower edu-
cation generally live in villages and in old age groups. There
is evidence that communities with predominant population
engaged in agriculture and lower level of education is di-
rectly associated with age and disappears as an independent
factor for the onset of hypertension 
21. Although there are
studies that indicate that lower socioeconomic status is asso-
ciated with a higher incidence of hypertension 
20, in our
study it was not the case. In the studied area hypertension in-
cludes both rich and poor groups of population.
Despite improving knowledge and treatment options for
controlling hypertension, the prevalence of patients with un-
controlled hypertension remains high in developed coun-
tries 
22, 23. Our research shows that with ¼ of the total popu-
lation, or even 54% of the population known to have hyper-
tension does not establish control over the height of arterial
pressure, indicating the ineffectiveness of treatment. Re-
search conducted in the United States indicated that pharma-
cological therapy provides control of hypertension in only
39% of patients treated in primary care, which coincides with
our findings 
16. Also, many prospective studies have demon-
strated the ineffectiveness of drugs in preventing complica-
tions of hypertension 
24. Medications maintenance of blood
pressure <  135/85 mmHg in hypertensive individuals does
not provide additional benefits in extending life and reducing
heart attack, angina or heart failure 
25, 26. Unfortunately, there
is a well-known problem of the influence of pharmaceutical
industry at all levels of care, in Serbia and in our circum-
stances the problem of hypertension is solved in curative
rather than preventive level. On the other hand, the develop-
ment capacity of secondary health care level in the field of
gerontology, and emergency services in urgent care situation
in the field over the past decade were the key reasons for the
comforting fact that in the Šumadija District in a 1998–2008
period revealed decline in mortality from hypertension-
derived diseases (ICD 10: I10 - I15) 
10.
Our results suggest that other cardiovascular diseases
such as myocardial infarction, angina pectoris, heart failure
and cerebrovascular stroke in ¾ patients were associated
with hypertension. Literature data indicate that the absolute
individual risk of developing complications of hypertension
and organ damage depends not only on the amount of blood
pressure, but also on other risks for cardiovascular disease
and associated clinical disorders. Therefore, it is necesary to
divert the struggle against hypertension from diagnosis and
treatment, to programs of prevention of hypertension and its
complications 
6, 27.
The results indicating that 53% of population suffers
from hypertension, 9% of the population do not know to
have hypertension, the incidence of hypertension exceeds
50% of population already in the age group of 45–54 years,
and that the incidence of other cardiovascular diseases is sig-
nificantly higher in patients with hypertension, may be con-
sidered alarming. Therefore, the focus of hypertension prob-
lem solving in Šumadija is just at the primary level of care
and implementation of effective intervention projects on pre-
vention and early detection of heart and blood vessels dis-
eases.
In Serbia there are no data on socio-economic impact of
diseases such as hypertension and development of its com-
plications. According to economic analysis of the American
Heart Association (AHA) in the U.S.A. in 2006 more than
430 billion dollars was spent for the diagnosis, outpatient and
inpatient care of patients with CVD, including the cost of
lost work capacity 
28. It is scientifically proven that the tech-
nique of detecting and reducing risk factors is very efficient
and cost-effective 
15, 29.
Our research shows that the target groups for preventive
action and early detection are: male sex, age of 25–44 years,
persons with lower education and rural population. Preven-
tion and early detection activities should focus precisely on
these risk groups in order to investigate the risk factors, their
prevention or modification, in order to prevent the start or
progress of the disease and to prevent disability and prema-
ture death.
The potential for improving population health in Šu-
madija lies in a comprehensive strategy to prevent and con-
trol hypertension, which would also improve promoting
health at population level, programs to prevent the disease
actively targeted to individuals and groups at high risk, and
maximum population coverage with systematic preventive
reviews.
Conclusion
Hypertension is present in 53% of population and its
prevalence in Šumadija increased in comparison to previous
studies in Serbia, which in some way indicates the ineffi-
ciency of primary health care level. About 54% of respon-
dents who know they have hypertension do not regulate
blood pressure levels, although they take medications. We
found 9% of new cases of hypertension, which indicates the
quality of primary care activities in the early detection.
The prevalence of hypertension is significantly higher
in males, in older age groups, in less educated people and
inhabitants of rural environment, so they should be the target
group for the application of the so-called high-risk strategy.
Newly discovered hypertension is more common in
men, middle aged, in the countryside, and they should be a
target for interventions to early detect the disease.
Using these strategies we can expected to reduce
comorbidity caused by hypertension, as confirmed by the as-
sociation of hypertension with myocardial infarction, angina
pectoris, other heart diseases and cerebrovascular crises.
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